Qiumeng Y. Liu

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

IL-13Rα2 in liver cancer: Endothelial target for precision therapy.

IL-13Rα2 in liver cancer: Endothelial target for precision therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 14, 2026

Multicenter machine learning model to predict very early recurrence after curative-intent resection of hilar cholangiocarcinoma.

Multicenter machine learning model to predict very early recurrence after curative-intent resection of hilar cholangiocarcinoma.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: December 21, 2025

SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis.

SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 19, 2025

SPP1+ Macrophages and the Orchestration of Spatially Organized Immunosuppression in Cancer.

SPP1+ Macrophages and the Orchestration of Spatially Organized Immunosuppression in Cancer.

Journal: Biomedicines

Published: December 04, 2025

EIF4A3-induced circEIF2S2 facilitates colorectal cancer growth, metastasis, and immune suppression via the miR-646/UHMK1 Axis.

EIF4A3-induced circEIF2S2 facilitates colorectal cancer growth, metastasis, and immune suppression via the miR-646/UHMK1 Axis.

Journal: International journal of biological macromolecules

Published: June 28, 2025

EIF4A3-induced circEIF2S2 facilitates colorectal cancer growth, metastasis, and immune suppression via the miR-646/UHMK1 Axis.

EIF4A3-induced circEIF2S2 facilitates colorectal cancer growth, metastasis, and immune suppression via the miR-646/UHMK1 Axis.

Journal: International journal of biological macromolecules

Published: June 28, 2025

Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma.

Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma.

Journal: Science immunology

Published: June 27, 2025

Erratum to: Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study.

Erratum to: Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study.

Journal: Science China. Life sciences

Published: June 11, 2025

NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinoma.

NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: January 09, 2025

CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression.

CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression.

Journal: Autophagy

Published: December 17, 2024

Colon cancer exosome-associated HSP90B1 initiates pre-metastatic niche formation in the liver by polarizing M1 macrophage into M2 phenotype.

Colon cancer exosome-associated HSP90B1 initiates pre-metastatic niche formation in the liver by polarizing M1 macrophage into M2 phenotype.

Journal: Biology direct

Published: December 09, 2024

Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma.

Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma.

Journal: Cell death & disease

Published: November 24, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026